Vatera Healthcare Partners appeared to be the VC, which was created in 2007. The main office of represented VC is situated in the New York. The venture was found in North America in United States.
This organization was formed by Michael Jaharis, Sundar Kodiyalam.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Vatera Healthcare Partners, startups are often financed by New Leaf Venture Partners, 5AM Ventures, Clarus Ventures. The meaningful sponsors for the fund in investment in the same round are New Leaf Venture Partners, 5AM Ventures, Clarus Ventures. In the next rounds fund is usually obtained by New Leaf Venture Partners, Clarus Ventures, 5AM Ventures.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight ImmusanT. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular fund investment industries, there are Medical, Health Diagnostics.
Speaking about the real fund results, this VC is 60 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. Comparing to the other companies, this Vatera Healthcare Partners performs on 9 percentage points less the average number of lead investments. The top activity for fund was in 2012.
Related Funds
Funds with similar focus
Fund Name | Location |
Arnoldo Mondadori Editore S.p.A | Italy, Lombardy, Milan |
Boulder Brands | Boulder, Colorado, United States |
Dianshi Equity Investment | China, Shanxi, Yuci |
Durable Capital Partners | Chevy Chase, Maryland, United States |
Magnum Technologies | - |
Ourpalm | Beijing, Beijing, China |
Partners Investment | Seoul, Seoul-t'ukpyolsi, South Korea |
Pinnacle Ventures | California, Menlo Park, United States |
Tianjin Boyi Chuangwei Touzi | China, Guangdong, Tianjin |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
ImmusanT | $40M | 14 Nov 2017 | Cambridge, Massachusetts, United States | ||
ImmusanT | $12M | 22 Dec 2014 | Cambridge, Massachusetts, United States | ||
ImmusanT | $20M | 13 Dec 2011 | Cambridge, Massachusetts, United States | ||
Pearl Therapeutics | $69M | 19 Oct 2010 | Morristown, New Jersey, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
ImmusanT | $40M | 14 Nov 2017 | Cambridge, Massachusetts, United States | ||
ImmusanT | $12M | 22 Dec 2014 | Cambridge, Massachusetts, United States | ||
ImmusanT | $20M | 13 Dec 2011 | Cambridge, Massachusetts, United States | ||
Pearl Therapeutics | $69M | 19 Oct 2010 | Morristown, New Jersey, United States |